CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Cytomx Therapeutics Inc Company Snapshot
Cytomx Therapeutics Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cytomx Therapeutics Inc with three other companies in this sector in the United States: Surface Oncology Inc (2018 sales of $59.42 million of which 100% was Pharmaceutical), Adaptive Biotechnologies Corp ($55.66 million of which 59% was Sequencing revenue), and bluebird bio Inc ($54.58 million of which 100% was Biological Products).

Sales Analysis. During the year ended December of 2018, sales at Cytomx Therapeutics Inc were $59.50 million. This is a decrease of 16.9% versus 2017, when the company's sales were $71.62 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Cytomx Therapeutics Inc
  Stock Performance Chart for Cytomx Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 6.29
(Figures in U.S. Dollars)
1 Week 0.5%   13 Weeks 5.7%  
4 Weeks -26.2%   52 Weeks -55.4%  
 
Cytomx Therapeutics Inc Key Data:
  Ticker: CTMX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 59,502,000
(Year Ending Jan 2019).
Employees: 139
  Currency: U.S. Dollars Market Cap: 285,732,484
  Fiscal Yr Ends: December Shares Outstanding: 45,426,468
  Share Type: Common Closely Held Shares: 1,228,294
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.